Venture Capital Firm | Contact, Portfolio & Investment Focus
series-a
$300M
$71M
Safar Partners Fund III, L.P. focuses on series-a investments, targeting companies at this specific growth phase.
Check size information is not publicly disclosed. Reach out directly to discuss investment amounts.
Arunas Chesonis; Nader Motamedy
Massachusetts, centered around Boston and Cambridge, is the nation's biotech and life sciences capital with world-class research institutions.
Visit Safar Partners Fund III, L.P.'s official website to find their contact information and pitch submission process.
Safar Partners Fund III, L.P.'s typical check size is not publicly disclosed. Contact the firm directly for investment range details.
Safar Partners Fund III, L.P. focuses on series-a investments. Companies at this stage typically have established product-market fit and are ready to scale.
Safar Partners Fund III, L.P.'s current deployment status may vary. Check their recent announcements or contact them directly.
Safar Partners Fund III, L.P. is headquartered in CAMBRIDGE, MA. They may consider investments from startups outside their immediate geography.
CONTRARY CAPITAL IV, LP
unknown
BluePointe Ventures SOF I, L.P.
pre-seed
Clean Energy Venture Fund II, LP
series-a
Altimeter Growth Olympic Fund II, L.P.
growth
Cybernetix Ventures Fund II, L.P.
series-a
Janus Henderson Biotech Innovation Fund II Ltd
series-b
Data Sources: SEC EDGAR filings, company disclosures, and verified public records.
Last updated: Dec 27, 2023